Rare lymphoma responds to R-CHOP

Patients with advanced nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) can be safely and effectively treated with R-CHOP*, according to a retrospective US study. Co-author Dr Chan Cheah, now at Sir Charles Gairdner Hospital in WA, told the limbic the rarity of the disease meant prospective studies were difficult. Yet it was important to try and clarify optimal therapy ...